Title: A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus
year: 2016
Journal: Autoimmun Rev
Volume: 15
Issue: 2
Pages: 124-38
Epubdate: 27/10/2015
date: Feb
Alternate Journal: Autoimmunity reviews
ISSN: 1568-9972
Article Number: 26497108
Keywords: Animals Antibodies, Antiphospholipid/blood Autoantibodies/*blood/*cerebrospinal fluid/immunology Humans Lupus Vasculitis, Central Nervous System/*diagnosis/immunology Prevalence Adjunct diagnostic tool Autoantibody Neuropsychiatric systemic lupus erythematosus (NPSLE)
Abstract: Neuropsychiatric systemic lupus erythematosus (NPSLE) is one of the most devastating presentations of SLE and comprises of psychiatric, central and peripheral neurological signs and symptoms. Previous studies suggest the possible associations between various autoantibodies (Abs) and NPSLE. The magnitudes of such association varied between studies. We performed a meta-analysis to pool data on serum and cerebrospinal fluid (CSF) levels and positivity of Abs in blood and cerebrospinal fluid in patients with NPSLE and SLE. A systematic literature search was conducted to identify studies that fulfilled inclusion criteria. A random-effects model was used to calculate overall combined odd ratio (OR) and mean levels with its corresponding 95% confidence interval to evaluate the relationship between individual Abs and NPSLE patients relative to SLE patients. Forty-one studies met the inclusion criteria and were used in this analysis. There was a significantly greater proportion of NPSLE patients who demonstrated positivity for serum anti-cardiolipin (aCL) Abs (OR=1.63, p=0.016), lupus anticoagulants (LA) Abs (OR=1.91 p=0.01), anti-phospholipid (APL) Abs (OR=2.08, p=0.001), anti-ribosomal P Abs (OR=2.29, p<0.001), anti-neuronal Abs (OR=9.50, p<0.001) as compared to SLE patients. In NPSLE patients, there was a significant increased prevalence of positive titres for CSF anti-neuronal Abs (OR=36.84, p=0.001) as compared to SLE patients. Among the 19 neuropsychiatric syndromes, the positivity of these serum autoantibodies were found specifically significantly associated with the manifestations of mood disorder, psychosis, cerebrovascular disease, seizure disorders, acute confusional state, cognitive dysfunction, headache, movement disorder, demyelinating syndrome and polyneuropathy, with ORs ranging from 1.84 to 4.73. Meta-regression identified proportion of women as significant moderator for the heterogeneity of aCL (p=0.004) and anti-neuronal Abs (p=0.0007); mean age for the heterogeneity of aCL (p=0.042) and LA (p=0.020) Abs, mean duration of illness for the heterogeneity of aCL Abs (p=0.035), and mean SLEDAI scores for the heterogeneity of anti-ribosomal P Abs (p=0.014). NPSLE patients are more likely to have elevated serum levels of aCL, LA, APL, anti-ribosomal P Abs and anti-neuronal Abs compared with SLE patients. Further research is required to evaluate the accuracy of using the above antibodies as an adjunct diagnostic tool in NPSLE.
Notes: 1873-0183 Ho, Roger C Thiaghu, C Ong, Huiyi Lu, Yanxia Ho, Cyrus S Tam, Wilson W Zhang, Melvyn W Journal Article Meta-Analysis Review Netherlands Autoimmun Rev. 2016 Feb;15(2):124-38. doi: 10.1016/j.autrev.2015.10.003. Epub 2015 Oct 23.
URL: http://www.sciencedirect.com/science/article/pii/S156899721500213X
URI: https://open-access.imh.com.sg/handle/123456789/5048
Authors Address: Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Department of Clinical Psychology and Psychiatry/School of Public Health, Zhejiang University College of Medicine, Hangzhou, China. Electronic address: A0068932@u.nus.edu. Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Institute of Mental Health, Singapore.
Database Provider: NLM
language: eng
Appears in Collections:2016

Files in This Item:
There are no files associated with this item.



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.